Skip to main content
Premium Trial:

Request an Annual Quote

Affy Promotes King to President; BIO Taps Taylor as Health VP; Phelps Joins Bar Harbor as President; and Others

NEW YORK (GenomeWeb News) - Affymetrix has promoted Kevin King to president of the company from his previous post as vice president of life sciences and executive vice president. King joined Affy in January of this year. Prior to that, he was CEO and president of Thomson Healthcare and also held executive-level roles at GE Healthcare and Hewlett-Packard.
 

John Taylor has been tapped to take the role of executive vice president of health with the Biotechnology Industry Organization. Taylor was an executive at Abbott, and held senior-level positions for 14 years at the US Food and Drug Administration.
 

Bar Harbor BioTechnology has hired Robert Phelps as president. Phelps comes to the company from Applied Biosystems. In the new job he will take over operations, and will manage marketing and sales. 
 

Australian researchers Peter Waterhouse and Ming-Bo Wang have won the Prime Minister’s Prize for Science. The scientists were recognized for their discovery of double-stranded RNA-induced gene silencing in plants.
 
The two have used gene silencing to allow plant genes to resist diseases, including Barley Yellow Dwarf Virus, which affects cereals such as wheat and barley. Broader applications for the research could include modifying oils to create biodiesel fuels.
 
The researchers work for Australia’s Commonwealth Scientific and Industrial Research Organization in Canberra.
 

GenTel Biosciences has appointed Reinhard Hiller and Jonathan Blackburn to its scientific advisory board. Hiller and Blackburn are scientists at the Center for Proteomic and Genome Research in Cape Town, South Africa.
 

Eragen has appointed Miguel Blanc as vice president of corporate development. Blanc previously was manager of global business development for GE Healthcare, executive account manager at Amersham Biosciences, and manager of business development at Motorola.
 

George Makhatadze is joining the Rensselaer Polytechnic Institute as a chaired professor in the school’s biocomputation and bioinformatics “constellation” — an interdisciplinary team of faculty and student researchers.
 
Makhatadze is on the editorial board of the Journal of Biological Chemistry and other publications, and is a member of the American Chemical Society and the Society for Biochemistry and Molecular Biology.
 
He joins RPI from Penn State University College of Medicine, where he was a professor of biochemistry and molecular biology and directed a graduate program in chemical biology for eight years.
 

ForteBio has named Joseph Keegan president and CEO. Keegan will replace founding CEO Winnie Wan, who will remain on the company’s board of directors.
 
Keegan formerly was president and CEO of Molecular Devices, which was acquired by MDS this year. He was also president of worldwide tissue culture and vice president and general manager of worldwide flow cytometry at Becton Dickinson.
 

Paul Sartori has taken the job of senior vice president of organizational development and human resources at BioTrove.
 
Sartori formerly was a partner at CHM Partners International, and was global vice president of human resources at CIBA-Corning Diagnostics, senior vice president of human resources and communications at CIBA-Geigy, and executive vice president of external affairs and human resources at Novartis.
 

ImaRx Therapeutics has named Richard Love to be chairman of the board of directors. Love formerly was chief operating officer for the Translational Genomics Research Institute. The company also tapped Garen Manvelian to be chief medical officer, and promoted Jennifer Marshal to vice president of corporate development. 
 

Algeta said this week that CFO Geir Christian Melen will resign to join Clavis Pharma as CEO. Melen will leave within six months, and the company is seeking a new CFO.
 

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.